PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Law, Genevieve
TI  - Thrombosis and Lymphoma Stalk Lupus Patients
DP  - 2012  01
TA  - MD Conference Express
PG  - 23--24
VI  - 12
IP  - 19
4099  - http://mdc.sagepub.com/content/12/19/23.short
4100  - http://mdc.sagepub.com/content/12/19/23.full
AB  - Patients with systemic lupus erythematosus (SLE) are at heightened risk of thrombosis [Mok CC et al. Arthritis Rheum 2005] and mortality [Cervera R et al. Medicine (Baltimore) 2003]. Additionally, women with SLE are also 2.05 to 2.27 times more likely to have a cerebral vascular accident)/myocardial infarction [Ward MM. Arthritis Rheum 1999 (Feb)]. This article discusses the use of hydroxychloroquine for the reduction of thrombosis in systemic lupus patients, and lymphoma risk in systemic lupus.